Clinical Trial Update: Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two to four months of combination regimens with DBOS and PBOS for adults with pulmonary tuberculosis; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• DBOS
• PBOS

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: TERMINATED